LINCOLN PHARMACEUTICALS LTD. - Board recommends Dividend

Lincoln Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2015, inter alia, has:<BR><BR>1. Recommended dividend of Re. 1.00(10%) per Equity Share of face value Rs. 10/- each.<BR><BR>2. Allotted 36,89,200 warrants convertible in to equal number of Equity shares on preferential basis to the promoters / promoters' group and persons other than the promoters / promoters group pursuant to the Securities And Exchange Board of India (Issue Of Capital And Disclosure Requirements) Regulations, 2009.<BR><BR>3. Approved and adopted the Code of Conduct for prohibition of Insider Trading as per Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015.